What is Shapumvilla used for in traditional Amazonian medicine?

Shapumvilla, a regional name for Croton lechleri (Dragon's Blood), is used topically in Amazonian indigenous medicine to stop bleeding, accelerate wound closure, treat bone fractures, and address skin infections, with the raw red latex applied directly to affected areas. Traditional healers also use diluted preparations internally for gastrointestinal conditions and as a general anti-inflammatory tonic, though these oral uses lack clinical validation.

How does Shapumvilla stop bleeding and promote wound healing?

The primary wound-healing agent in Shapumvilla is taspine, an alkaloid that acts as a fibroblast chemotactic factor, stimulating fibroblast migration into wound sites, upregulating collagen type I and III synthesis, and promoting angiogenesis in granulation tissue. The latex resin also physically forms a protective astringent film over wounds that mechanically supports local coagulation, complementing taspine's cellular healing activity.

Is there scientific evidence that Shapumvilla (Croton lechleri) fights cancer?

Preclinical in vitro studies show that taspine and twig polyphenolic extracts from Croton lechleri induce apoptosis and G1/G2M cell cycle arrest in A375 melanoma cells at IC50 values of 13.31–249.8 µg/mL, and methanol leaf extracts trigger apoptosis in HeLa, SW-480, and MDA-MB-231 cancer lines at approximately 17 µg/mL. However, no human clinical trials exist, so these findings cannot be interpreted as evidence of anticancer efficacy in people.

What are the known side effects and safety concerns of Shapumvilla?

No adverse effects from topical use have been systematically documented, but this reflects a lack of formal safety studies rather than confirmed safety. Scientists who have studied Croton lechleri bark extracts specifically call for toxicological and mutagenicity testing before pharmaceutical or food use, because the alkaloid and terpenoid content poses theoretical genotoxic risk that has not been formally evaluated.

What is the correct dose of Shapumvilla supplement?

No standardized supplemental dose for Shapumvilla or Croton lechleri has been established for any human indication, as no clinical trials have determined safe or effective doses. Traditional use involves direct topical application of undiluted latex to wounds, while laboratory studies use aqueous bark extracts at 35°C for 90 minutes or ethanol twig extracts at concentrations that do not translate directly to human oral dosing without pharmacokinetic data.

Does Shapumvilla interact with blood thinners or anticoagulant medications?

Shapumvilla contains potent hemostatic compounds that promote blood clotting, which may counteract or reduce the effectiveness of anticoagulants like warfarin or antiplatelet drugs such as aspirin. Concurrent use with blood-thinning medications requires medical supervision to prevent reduced therapeutic efficacy or increased thrombotic risk. Consult with a healthcare provider before combining Shapumvilla with any anticoagulant or antiplatelet therapy.

Is Shapumvilla safe for pregnant or breastfeeding women?

There is insufficient clinical safety data on Shapumvilla use during pregnancy and lactation, and traditional use does not guarantee safety for these sensitive populations. The alkaloid taspine and other bioactive constituents have not been adequately studied in pregnant or nursing women, making risk assessment impossible. Pregnant and breastfeeding women should avoid Shapumvilla supplementation until adequate safety studies are conducted.

What is the difference between Shapumvilla latex and Shapumvilla capsule or extract forms?

Fresh Shapumvilla latex (also called dragon's blood) contains the complete synergistic profile of taspine, diterpenes, and resinous compounds with maximal hemostatic potency, while processed capsules or extracts may lose volatile components or have standardized but reduced alkaloid concentrations depending on extraction methods. Latex form typically delivers faster topical hemostasis for wounds, whereas oral capsules or extracts provide more convenient systemic anti-inflammatory benefits with slower absorption. Bioavailability and efficacy vary significantly between forms, with latex showing superior bleeding control but extracts offering better oral tolerability and shelf stability.

Shapumvilla

Shapumvilla (Croton lechleri) exerts its primary coagulant, wound-healing, anti-inflammatory, and anticancer activities through the alkaloid taspine, clerodane diterpenes, and phenolic compounds including gallic acid and catechins, which together promote fibroblast chemotaxis, collagen fibrogenesis, and selective apoptosis in malignant cells. In vitro studies demonstrate IC50 values of 13.31–249.8 µg/mL against human melanoma (A375) and colorectal (HT29) cell lines, with methanol leaf extracts inducing apoptosis at 17 µg/mL in HeLa, SW-480, and MDA-MB-231 cancer cell lines, though human clinical trial data validating these effects remain absent.

Category: Amazonian Evidence: 1/10 Tier: Preliminary

Origin & History

Shapumvilla is a regional vernacular designation applied to Croton lechleri (Euphorbiaceae), a fast-growing canopy tree native to the upper Amazon basin, including Peru, Ecuador, Colombia, and Bolivia, typically found at elevations between 200 and 1,800 meters in moist tropical forest margins and secondary growth areas. The tree thrives in disturbed soils along riverbanks and forest clearings, where it colonizes rapidly after canopy disturbance, producing a characteristic deep-red latex when the bark is incised. Indigenous Amazonian communities have cultivated and wildcrafted the tree for generations, harvesting its sap and bark primarily during dry seasons when latex yield and resin concentration are highest.

Historical & Cultural Context

Croton lechleri, known widely as Sangre de Drago (Dragon's Blood) and regionally as Shapumvilla among certain Amazonian communities, has been central to indigenous healing traditions of Peru, Ecuador, Bolivia, and Colombia for centuries, where its vivid red latex was regarded as a sacred wound-closing agent and attributed with broad curative powers. Healers of the Quechua, Shuar, and various lowland Amazonian ethnic groups applied the raw sap directly to lacerations, bone fractures, skin infections, ulcers, and dermatological conditions, sometimes ingesting diluted preparations for gastrointestinal complaints and as a purported anticancer tonic. The resin's striking blood-red color conferred symbolic and spiritual significance within shamanic practice, aligning it with vitality, protection, and regenerative healing in Amazonian cosmology. European botanical documentation of Dragon's Blood resin dates to the sixteenth-century Spanish chronicles of the New World, and the material has been described in pharmacognostic literature since the early twentieth century, though systematic phytochemical characterization did not begin until the latter decades of the twentieth century.

Health Benefits

- **Wound Healing and Hemostasis**: The alkaloid taspine drives fibroblast chemotaxis, collagen fibrogenesis, and epithelial cell proliferation, while the latex's astringent resinous compounds physically promote local coagulation and cessation of bleeding at wound sites.
- **Anti-Inflammatory Activity**: Clerodane and labdane diterpenes, alongside phenolic compounds such as catechin and epicatechin, modulate inflammatory signaling pathways, reducing pro-inflammatory mediator release in preclinical models consistent with traditional use for trauma and fracture care.
- **Antioxidant Protection**: Bark extracts yield total phenolic content of 8.8–46.57 mg GAE/g, with DPPH radical scavenging capacity measured at 81.17–283 µmol Trolox equivalents per gram, driven principally by gallic acid, syringic acid, and flavonoids including rutin and vitexin.
- **Selective Anticancer Cytotoxicity**: Taspine and twig polyphenolic fractions induce dose-dependent apoptosis and necrosis in A375 melanoma and HT29 colon cancer cell lines, with cell cycle arrest at G1 and G2/M phases and suppressed S-phase DNA synthesis detected via EdU assay, while showing comparatively lower cytotoxicity to normal HaCat keratinocytes.
- **Antimicrobial Activity**: Bark and latex extracts exhibit broad-spectrum antimicrobial properties attributed to phenolic acids and terpenoid constituents, supporting traditional Amazonian use for infected wounds and skin conditions, though formal minimum inhibitory concentration data require further systematic characterization.
- **Angiogenesis Promotion in Wound Repair**: Taspine specifically stimulates angiogenic processes at wound margins, enhancing vascularization of granulation tissue and accelerating the proliferative phase of cutaneous repair in preclinical wound models.
- **Precarcinogen Biotransformation Inhibition**: Flavonols identified in twig and leaf extracts, including rutin and vitexin, inhibit phase I biotransformation enzymes responsible for activating dietary and environmental precarcinogens, suggesting a chemopreventive mechanism complementary to direct cytotoxic activity.

How It Works

Taspine, the principal alkaloid of Croton lechleri latex, promotes wound healing by acting as a chemotactic signal for fibroblasts, upregulating collagen type I and III synthesis, and stimulating endothelial cell migration and angiogenesis, partially through interaction with epidermal growth factor receptor (EGFR) signaling pathways. In cancer cell lines, taspine and associated clerodane diterpenes induce intrinsic apoptotic pathway activation evidenced by Annexin V/PI positivity, arrest cell cycle progression at the G1 and G2/M checkpoints by modulating cyclin-dependent kinase (CDK) activity, and reduce DNA replication as confirmed by suppressed EdU incorporation in S-phase, with selective toxicity favoring malignant over normal epithelial cells. Phenolic compounds—particularly gallic acid, catechin, and epicatechin extracted from bark—scavenge reactive oxygen species (ROS) directly via hydrogen atom transfer and single electron transfer mechanisms, and flavonols such as rutin and vitexin inhibit cytochrome P450 enzyme-mediated precarcinogen bioactivation. Crolechinic acid and korberin-type clerodane lactones in bark contribute additional anti-inflammatory effects, likely by inhibiting NF-κB transcriptional activation and suppressing COX-mediated prostaglandin biosynthesis.

Scientific Research

The existing evidence base for Shapumvilla/Croton lechleri consists entirely of in vitro cell culture studies and ethnopharmacological documentation, with no published randomized controlled trials, cohort studies, or formal human clinical trials reporting quantitative outcomes for any indication. In vitro cytotoxicity work has characterized IC50 values of 13.31–249.8 µg/mL for twig ethanol extracts against A375 melanoma and HaCat cell lines using MTT and trypan blue exclusion assays, and methanol leaf extracts have demonstrated apoptosis induction at 17 µg/mL across HeLa, SW-480, and MDA-MB-231 cancer cell lines. Chemometric extraction optimization studies have rigorously quantified bark phenolic content (8.8–46.57 mg GAE/g) and antioxidant capacity (81.17–283 µmol Trolox/g DPPH), establishing reproducible analytical benchmarks, but translational pharmacokinetic and bioavailability data in humans are entirely absent. Regulatory and scientific bodies including primary researchers explicitly caution that comprehensive toxicological and mutagenicity evaluation must precede any pharmaceutical or food-grade application, reflecting the preliminary and preclinical nature of the current evidence.

Clinical Summary

No human clinical trials have been conducted or published for Shapumvilla or its Croton lechleri source material in any indication, including wound healing, hemostasis, or oncology. The entire clinical-adjacent evidence consists of in vitro cytotoxicity and antioxidant assays, with taspine-focused preclinical pharmacology providing mechanistic plausibility but not validated human efficacy or safety data. Traditional Amazonian use reports no adverse effects from topical latex application to wounds and fractures, constituting anecdotal observational evidence without controlled methodology, blinding, or systematic outcome measurement. Confidence in all proposed clinical benefits must therefore be rated as very low pending formal phase I safety trials and mechanistic pharmacokinetic studies in human volunteers.

Nutritional Profile

Croton lechleri latex and extracts are not consumed as a macronutrient source and do not contribute meaningfully to dietary protein, carbohydrate, fat, or caloric intake. The pharmacologically significant constituents include: taspine alkaloid (principal bioactive in latex, concentration varies by harvest season and tree age); clerodane, labdane, abietane, tigliane, ent-kaurane, and cembranolide diterpenes in latex and bark; total phenolic content of bark extracts 8.8–46.57 mg gallic acid equivalents per gram dry weight; identified phenolic acids including gallic acid and syringic acid; flavan-3-ols catechin and epicatechin; flavonol glycosides rutin and vitexin in leaf and twig extracts; and crolechinic acid and korberin A/B clerodane lactones in bark. Sesquiterpenes are present in stem bark essential oil. Bioavailability of taspine and phenolic compounds following oral ingestion in humans has not been characterized; aqueous extraction at 35°C optimizes phenolic yield, suggesting water solubility for the principal antioxidant fraction.

Preparation & Dosage

- **Traditional Latex Application**: Raw red sap is collected directly from bark incisions and applied topically to wounds, cuts, and fractures; no standardized volume per application is established in the literature.
- **Aqueous Bark Extract**: Optimal phenolic extraction achieved with water at 35°C for 90 minutes (pressurized liquid extraction); yields 8.8–46.57 mg GAE/g total phenolics; no human dose established.
- **Soxhlet Ethanol Extract (Twigs/Bark)**: Used in preclinical cytotoxicity studies at concentrations of 13.31–249.8 µg/mL in cell culture; no equivalent human oral dose has been derived or validated.
- **Methanolic Leaf Extract**: Prepared by cold maceration or reflux in methanol; cytotoxic concentrations in vitro are approximately 17 µg/mL; human bioequivalent oral dosing is unknown.
- **Steam-Distilled Essential Oil (Stem Bark)**: Contains sesquiterpenes; no therapeutic dosing data exist for this form in humans.
- **Standardization**: No commercial standardization to taspine content, total phenolics, or specific diterpenes has been formally established; human dosing guidelines do not exist in any reviewed source.

Synergy & Pairings

Traditional Amazonian healers have combined Croton lechleri latex with wound-packing plant materials such as Uncaria tomentosa (Cat's Claw) bark, which provides complementary NF-κB inhibition and immunomodulatory alkaloids (oxindole alkaloids), potentially reinforcing the anti-inflammatory and tissue-repair mechanisms of taspine through additive suppression of pro-inflammatory cytokine cascades. The phenolic fraction of Croton lechleri—particularly gallic acid and catechin—may exhibit synergistic antioxidant activity when combined with vitamin C (ascorbic acid), as ascorbate regenerates oxidized phenolic radicals and prolongs their ROS-scavenging cycle, a mechanism documented for related polyphenol-ascorbate pairs in vitro. No formal synergy studies or validated supplement stack protocols have been published for Shapumvilla specifically, and all proposed combinations remain theoretical extrapolations from mechanistic pharmacology.

Safety & Interactions

Topical application of Croton lechleri latex has been used extensively in Amazonian folk medicine with no systematic reports of adverse reactions, though this evidence is anecdotal and unsupported by controlled safety studies or pharmacovigilance data. Primary researchers explicitly recommend comprehensive toxicological and mutagenicity evaluation before any pharmaceutical or food-grade development, specifically citing the presence of alkaloids (including taspine) and terpenoid constituents that require genotoxicity screening; no LD50, NOAEL, or maximum safe dose has been established for any route of administration in humans. Drug interaction data are entirely absent from the published literature; the presence of alkaloids and flavonoids capable of modulating cytochrome P450 enzyme activity raises theoretical concerns regarding interactions with anticoagulants, chemotherapeutic agents, and drugs with narrow therapeutic indices. Use during pregnancy or lactation cannot be considered safe given the complete absence of reproductive toxicology data and the known biological activity of taspine on cell proliferation and angiogenesis.